| Revenue | DKK 514K | -20% |
| EBITDA | DKK -145K | -427% |
| Net profit | DKK -165K | -534% |
| Total assets | DKK 316K | +117% |
| Equity | DKK 71K | +342% |
| Employees | 1 | — |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Revenue | 1.444 | 220 | 463 | 642 | 514 |
| Staff expenses | -780 | -213 | -496 | -669 | -659 |
| EBITDA | 664 | 7 | -33 | -28 | -145 |
| Depreciation & amort. | -0 | -0 | -0 | -1 | -2 |
| EBIT | 664 | 7 | -33 | -29 | -147 |
| Net financials | 0 | -0 | 1 | -4 | -2 |
| Profit before tax | 664 | 7 | -32 | -32 | -150 |
| Tax | 167 | 2 | -7 | -6 | 16 |
| Net profit | 497 | 5 | -25 | -26 | -165 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Total assets | 1.460 | 173 | 224 | 146 | 316 |
| Equity | 926 | 72 | 42 | 16 | 71 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 535 | 101 | 182 | 129 | 245 |
| Total debt | 535 | 101 | 182 | 129 | 245 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LA Founder | Founder | 2010 | — | — |
SB Management | Management | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2016 | — | — | |
| Chairman | 2016 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2010 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Pharmalex Nordic ApS | Company | 100.0% | 100.0% | 2017 |
| Individual | 100.0% | 100.0% | 2010 | |
PharmaLex Denmark A/S | Company | 100.0% | 100.0% | 2017 |
| Person | Role here | Other companies |
|---|---|---|
| Lindeq AS | Founder | 0 companies |
| Solveig Blomvik | Management | 0 companies |
| Raphael Troost | Board of Directors | 0 companies |
| Steen Lindequist | Chairman | 0 companies |
| Jonathan Tjoa Algreen | Chairman | 0 companies |
| Anders Fage Jensen | Board of Directors | 0 companies |